King & Spalding represented Novartis on the deal.The ECJ has ruled in a judgment of November 17, 2022 on the requests for preliminary rulings from courts…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now